Article Content

TEST INSTRUCTIONS

  

* Read the article.

 

* Take the test, recording your answers in the test answers section (Section B) of the NCPD enrollment form. Each question has only one correct answer.

 

* Complete registration information (Section A) and course evaluation (Section C).

 

* Mail completed test with registration fee to: Lippincott Professional Development, CE Group, 74 Brick Blvd., Bldg., 4 Suite 206A, Brick, NJ 08723.

 

* Within 4-6 weeks after your NCPD enrollment form is received, you will be notified of your test results.

 

* If you pass, you will receive a certificate of earned contact hours and answer key. If you fail, you have the option of taking the test again at no additional cost.

 

* Questions? Contact Lippincott Professional Development: 800-787-8985

 

* There's only one correct answer for each question. A passing score for this test is 7 correct answers.

 

This article has been approved by the Orthopaedic Nurses Certification Board for Category B credit toward recertification as an ONC.

 

* For questions, contact Lippincott Professional Development: 1-800-787-8985.

 

* Registration deadline is December 6, 2024.

 

 

PROVIDER ACCREDITATION

 

Lippincott Professional Development will award 2.5 contact hours for this nursing continuing professional development activity.

 

Lippincott Professional Development is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

 

This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for 2.5 contact hours. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia, Georgia, and Florida, CE Broker #50-1223. Your certificate is valid in all states.

 

Disclosure: The authors and planners have disclosed no potential conflicts of interest, financial or otherwise.

 

Payment and Discounts: The registration fee for this test is $12.50 for NAON members and $25.00 for nonmembers.

 

NCPD TEST QUESTIONS

LEARNING OUTCOME: Healthcare providers will demonstrate knowledge of the findings of a research study that examined nurses' knowledge, confidence, and ability to recognize, prevent, and treat postoperative opioid-induced respiratory depression by achieving a minimum score of 70% on the outcomes-based posttest.

 

LEARNING OBJECTIVES: After completing this continuing professional development activity, the participant will be able to apply knowledge gained to:

 

1. Select the evidence the authors considered when planning their study of nurses' knowledge, confidence, and ability to recognize, prevent, and treat postoperative opioid-induced respiratory depression.

 

2. Identify the components of the methodology and implementation of the authors' study.

 

3. Choose the results of the authors' study that demonstrated the effects of their intervention.

 

 

1. According to Brant and colleagues and others, patients who have which of the following conditions are at an elevated risk for developing opioid-induced respiratory depression (OIRD)?

 

a. renal disease

 

b. gastrointestinal disease

 

c. musculoskeletal disorders

 

2. Gupta and colleagues and others reported that oversedation is more likely in patients who receive a

 

a. short-acting opioid.

 

b. corticosteroid concurrently with an opioid.

 

c. benzodiazepine concurrently with an opioid.

 

3. Compared with the Richmond Agitation Sedation Scale (RASS), according to Nisbet and Mooney-Cotter, the Pasero Opioid-Induced Sedation Scale (POSS)

 

a. scored lower in ease of use.

 

b. demonstrated slightly poorer reliability and validity.

 

c. scored higher in information provided to use to make clinical decisions.

 

4. According to Smith and colleagues, after interventions delivered through multiple formats, nurses were better able to

 

a. identify patients at risk for opioid-related oversedation.

 

b. recognize small changes in cognition of patients receiving sedation.

 

c. improve protocols for monitoring sedation during opioid administration.

 

5. Ramoo and colleagues reported that an intervention with didactic sessions followed by bedside practice resulted in significant increases in the nurses' knowledge related to

 

a. opioid dosing.

 

b. sedation management.

 

c. drug-drug interactions.

 

6. The OIRD Education Program Content that comprised the intervention for the authors' evidence-based project included which of the following topics?

 

a. history of substance use disorder

 

b. onset, peak, and half-life of opioids

 

c. physical and psychiatric comorbidities

 

7. The questions on the Opioid Knowledge Self-Assessment the authors used to measure participants' OIRD knowledge covered which of the following topics?

 

a. comparative dosing between two different opioids

 

b. strategies for reducing common adverse effects

 

c. administration guidelines for reversal agents

 

8. Results of the authors' data analysis demonstrated that, compared with pretest scores, the post-test scores showed a

 

a. slight but insignificant increase in the nurses' knowledge of OIRD.

 

b. statistically significant increase in the nurses' knowledge of OIRD.

 

c. slight but insignificant decrease in the nurses' knowledge of OIRD.

 

9. After the intervention, comparison of pretest and post-test scores showed no statistically significant increase in the nurses' level of confidence in

 

a. having the ability to recognize opioid-induced side effects.

 

b. being able to select appropriate doses based on the patients' condition.

 

c. having enough knowledge to understand who is at risk for opioid-related side effects.

 

10. Nurses overwhelmingly rated that they strongly agreed or agreed that the POSS instrument

 

a. supported safe practice.

 

b. was beneficial, but could have been easier to use.

 

c. should have identified more interventions for patients receiving opioids.

 

  

Figure. No caption a... - Click to enlarge in new windowFigure. No caption available.